Home LiteratureArticle Details
PMID: 15012588 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Structural analysis and tissue localization of human C4.4A: a protein homologue of the urokinase receptor.

The Biochemical journal ·Vol. 380 ·No. Pt 3 ·2004-06-15 ·Pages 845-57

Hansen LV, Gårdsvoll H, Nielsen BS, Lund LR, Danø K, Jensen ON, Ploug M

Abstract

C4.4A, a structural homologue of the urokinase-type plasminogen activator receptor (uPAR), was originally identified as a metastasis-associated membrane protein, but little is known about its structural and functional properties. Therefore, we expressed, purified and characterized a soluble truncated form of human C4.4A, and used this protein to produce specific polyclonal anti-C4.4A antibodies. By immunohistochemistry we observed a pronounced surface staining for C4.4A in suprabasal keratinocytes of chronic human wounds and found C4.4A expression markedly upregulated in migrating keratinocytes during re-epithelisation of incisional skin wounds. Phorbol-ester-induced hyperplasia of mouse skin is also accompanied by a significant induction of C4.4A expression in the multilayered, suprabasal keratinocytes. C4.4A contains two Ly-6 (leucocyte antigen 6)/uPAR/alpha-neurotoxin modules. Our recombinant human C4.4A is extensively modified by post-translational glycosylation, which include 5-6 N-linked carbohydrates primarily located in or close to its second Ly-6/uPAR/alpha-neurotoxin module and approximately 15 O-linked carbohydrates clustered in a Ser/Thr/Pro-rich region at the C-terminus. A highly protease-sensitive region (Tyr200-Arg204) is located between these two clusters of N- and O-linked carbohydrates. The natural, glycolipid-anchored C4.4A from amnion membranes of human term placenta exhibits similar properties. Using recombinant, soluble C4.4A or MCF 7 cells, which express significant amounts of GPI-anchored C4.4A, we find no evidence for an interaction between C4.4A and uPA, a property suggested previously for rat C4.4A. Collectively these data indicate that C4.4A, although being a structural homologue of uPAR, is unlikely to have a functional overlap with uPAR.

MeSH Terms
Amino Acid Sequence Animals Breast Neoplasms/pathology Cell Adhesion Molecules/biosynthesis,chemistry,genetics,metabolism Dermatologic Surgical Procedures GPI-Linked Proteins Humans Hyperplasia/chemically induced,metabolism Immunohistochemistry Mice Mice, Inbred C57BL Molecular Sequence Data Peptide Fragments/chemistry Peptide Mapping/methods Placenta/chemistry Protein Interaction Mapping/methods Protein Processing, Post-Translational/genetics Receptors, Cell Surface/biosynthesis,chemistry,genetics,metabolism Receptors, Urokinase Plasminogen Activator Recombinant Fusion Proteins/biosynthesis,genetics Sequence Homology, Amino Acid Skin/chemistry,pathology Tetradecanoylphorbol Acetate/adverse effects,analogs & derivatives Wound Healing
Chemicals
Cell Adhesion Molecules GPI-Linked Proteins LYPD3 protein, human PLAUR protein, human Peptide Fragments Plaur protein, mouse Plaur protein, rat Receptors, Cell Surface Receptors, Urokinase Plasminogen Activator Recombinant Fusion Proteins phorbolol myristate acetate Tetradecanoylphorbol Acetate
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Hansen Line V
Finsen Laboratory, Rigshospitalet, Strandboulevarden 49, DK-2100 Copenhagen, Denmark.
Gårdsvoll Henrik
Nielsen Boye S
Lund Leif R
Danø Keld
Jensen Ole N
Ploug Michael
References (37)
37 references, click to expand
  1. Localization of the disulfide bonds in the NH2-terminal domain of the cellular receptor for human urokinase-type plasminogen activator. A domain structure belonging to a novel superfamily of glycolipid-anchored membrane proteins.
    J Biol Chem. 1993 Aug 15;268(23):17539-46 PMID: 8394346
  2. The receptor for urokinase-type plasminogen activator is deficient on peripheral blood leukocytes in patients with paroxysmal nocturnal hemoglobinuria.
    Blood. 1992 Mar 15;79(6):1447-55 PMID: 1312369
  3. Structure-function relationships in the receptor for urokinase-type plasminogen activator. Comparison to other members of the Ly-6 family and snake venom alpha-neurotoxins.
    FEBS Lett. 1994 Aug 1;349(2):163-8 PMID: 8050560
  4. The receptor for urokinase-type plasminogen activator is not essential for mouse development or fertility.
    J Biol Chem. 1995 Jul 14;270(28):16886-94 PMID: 7622505
  5. How glycosylphosphatidylinositol-anchored membrane proteins are made.
    Annu Rev Biochem. 1995;64:563-91 PMID: 7574493
  6. Differential expression of urokinase-type plasminogen activator, its receptor, and inhibitors in mouse skin after exposure to a tumor-promoting phorbol ester.
    J Invest Dermatol. 1996 Apr;106(4):622-30 PMID: 8617995
  7. Generation and characterization of urokinase receptor-deficient mice.
    J Clin Invest. 1996 Feb 1;97(3):870-8 PMID: 8609247
  8. Urokinase-type plasminogen activation in three human breast cancer cell lines correlates with their in vitro invasiveness.
    Clin Exp Metastasis. 1996 May;14(3):297-307 PMID: 8674284
  9. Structure-function relationships of the complement regulatory protein, CD59.
    Blood Cells Mol Dis. 1996;22(3):281-96 PMID: 9075580
  10. O-GLYCBASE Version 3.0: a revised database of O-glycosylated proteins.
    Nucleic Acids Res. 1998 Jan 1;26(1):387-9 PMID: 9399880
  11. The intact urokinase receptor is required for efficient vitronectin binding: receptor cleavage prevents ligand interaction.
    FEBS Lett. 1997 Dec 22;420(1):79-85 PMID: 9450554
  12. Anterior specification of embryonic ectoderm: the role of the Xenopus cement gland-specific gene XAG-2.
    Mech Dev. 1998 Mar;72(1-2):115-30 PMID: 9533957
  13. Glycosylation profile of a recombinant urokinase-type plasminogen activator receptor expressed in Chinese hamster ovary cells.
    J Biol Chem. 1998 May 29;273(22):13933-43 PMID: 9593742
  14. Concepts and principles of O-linked glycosylation.
    Crit Rev Biochem Mol Biol. 1998;33(3):151-208 PMID: 9673446
  15. Differential roles for disulfide bonds in the structural integrity and biological activity of kappa-Bungarotoxin, a neuronal nicotinic acetylcholine receptor antagonist.
    Biochemistry. 1998 Sep 1;37(35):12166-71 PMID: 9724529
  16. Immunohistochemical identification of the receptor for urokinase plasminogen activator associated with fibrin deposition in normal and ectopic human placenta.
    Placenta. 1998 Sep;19(7):501-8 PMID: 9778123
  17. Cloning and functional characterization of a new phosphatidyl-inositol anchored molecule of a metastasizing rat pancreatic tumor.
    Oncogene. 1998 Oct 15;17(15):1989-2002 PMID: 9788443
  18. Sample purification and preparation technique based on nano-scale reversed-phase columns for the sensitive analysis of complex peptide mixtures by matrix-assisted laser desorption/ionization mass spectrometry.
    J Mass Spectrom. 1999 Feb;34(2):105-16 PMID: 10093212
  19. Plasma urokinase receptor levels in patients with colorectal cancer: relationship to prognosis.
    J Natl Cancer Inst. 1999 May 19;91(10):869-74 PMID: 10340907
  20. Insect cells as hosts for the expression of recombinant glycoproteins.
    Glycoconj J. 1999 Feb;16(2):109-23 PMID: 10612411
  21. Soluble urokinase receptor levels correlate with number of circulating tumor cells in acute myeloid leukemia and decrease rapidly during chemotherapy.
    Cancer Res. 2000 Dec 15;60(24):7126-32 PMID: 11156421
  22. The murine receptor for urokinase-type plasminogen activator is primarily expressed in tissues actively undergoing remodeling.
    J Histochem Cytochem. 2001 Feb;49(2):237-46 PMID: 11156692
  23. Cloning of the human homologue of the metastasis-associated rat C4.4A.
    Gene. 2001 Jan 10;262(1-2):35-41 PMID: 11179665
  24. Upregulation of C4.4A expression during progression of melanoma.
    J Invest Dermatol. 2001 Feb;116(2):344-7 PMID: 11180013
  25. Identification of genes involved in human urothelial cell-matrix interactions: implications for the progression pathways of malignant urothelium.
    Cancer Res. 2001 Feb 15;61(4):1678-85 PMID: 11245483
  26. Collagenase-3 expression in breast myofibroblasts as a molecular marker of transition of ductal carcinoma in situ lesions to invasive ductal carcinomas.
    Cancer Res. 2001 Oct 1;61(19):7091-100 PMID: 11585740
  27. The fibrinolytic receptor for urokinase activates the G protein-coupled chemotactic receptor FPRL1/LXA4R.
    Proc Natl Acad Sci U S A. 2002 Feb 5;99(3):1359-64 PMID: 11818541
  28. hAG-2 and hAG-3, human homologues of genes involved in differentiation, are associated with oestrogen receptor-positive breast tumours and interact with metastasis gene C4.4a and dystroglycan.
    Br J Cancer. 2003 Feb 24;88(4):579-85 PMID: 12592373
  29. Sensitive and specific enzyme-linked immunosorbent assay for urokinase-type plasminogen activator and its application to plasma from patients with breast cancer.
    J Lab Clin Med. 1988 Jan;111(1):42-51 PMID: 3121772
  30. Amino acid analysis: determination of cysteine plus half-cystine in proteins after hydrochloric acid hydrolysis with a disulfide compound as additive.
    Anal Biochem. 1989 Mar;177(2):318-22 PMID: 2729552
  31. Determination of amino acid compositions and NH2-terminal sequences of peptides electroblotted onto PVDF membranes from tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis: application to peptide mapping of human complement component C3.
    Anal Biochem. 1989 Aug 15;181(1):33-9 PMID: 2817381
  32. Cloning and expression of the receptor for human urokinase plasminogen activator, a central molecule in cell surface, plasmin dependent proteolysis.
    EMBO J. 1990 Feb;9(2):467-74 PMID: 1689240
  33. Cellular receptor for urokinase plasminogen activator. Carboxyl-terminal processing and membrane anchoring by glycosyl-phosphatidylinositol.
    J Biol Chem. 1991 Jan 25;266(3):1926-33 PMID: 1846368
  34. Prediction of human mRNA donor and acceptor sites from the DNA sequence.
    J Mol Biol. 1991 Jul 5;220(1):49-65 PMID: 2067018
  35. Cell-induced potentiation of the plasminogen activation system is abolished by a monoclonal antibody that recognizes the NH2-terminal domain of the urokinase receptor.
    FEBS Lett. 1991 Aug 19;288(1-2):233-6 PMID: 1715292
  36. Assignment of the urokinase-type plasminogen activator receptor gene (PLAUR) to chromosome 19q13.1-q13.2.
    Am J Hum Genet. 1992 Mar;50(3):492-7 PMID: 1311495
  37. Ligand interaction between urokinase-type plasminogen activator and its receptor probed with 8-anilino-1-naphthalenesulfonate. Evidence for a hydrophobic binding site exposed only on the intact receptor.
    Biochemistry. 1994 Aug 2;33(30):8991-7 PMID: 8043585
Article Info
Journal
The Biochemical journal
Abbr.
Biochem J
ISSN
1470-8728
Published
2004-06-15
Pages
845-57
Language
English
Region
England
NLM ID
2984726R
PMCID
PMC1224211
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com